Steven L. Hoerter - 15 Dec 2021 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role: President and CEO, Director
Signature: /s/ Jeffrey Held, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 15 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 17 Dec 2021, 15:10:18 UTC
Previous filing: 16 Aug 2021
Next filing: 20 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DCPH	Common Stock						40,695	15 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DCPH	Stock Option (Right to Buy)	Award	$0	+270,357		$0.000000	270,357	15 Dec 2021	Common Stock	270,357	$9.23	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan (the "2017 Plan"). The option shall vest in two equal installments on June 15, 2022 and June 15, 2023, subject to continuous service with the Issuer or a Subsidiary (as defined in the 2017 Plan) through each vesting date.